Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Oct 28.
Published in final edited form as: Neuroepidemiology. 2015 Oct 28;45(3):152–160. doi: 10.1159/000441084

Causes of Death Data in the Global Burden of Disease Estimates for Ischemic and Hemorrhagic Stroke

Thomas Truelsen 1, Lars-Henrik Krarup 2, Helle Iversen 3, George A Mensah 4, Valery Feigin 5, Luciano Sposato 6, Mohsen Naghavi 7
PMCID: PMC4635662  NIHMSID: NIHMS726191  PMID: 26505189

Abstract

Background

Stroke mortality estimates in the Global Burden of Disease (GBD) study are based on routine mortality statistics and redistribution of ill-defined codes that cannot be a cause of death, the so-called “garbage codes”. This study describes the contribution of these codes to stroke mortality estimates.

Methods

All available mortality data were compiled and non-specific cause codes were redistributed based on literature review and statistical methods. Ill-defined codes were redistributed to their specific cause of disease by age, sex, country, and year. The reassignment was done based on the international classification of diseases and the pathology behind each code by checking multiple causes of death and literature review.

Results

Unspecified stroke, and primary and secondary hypertension are leading contributing “garbage codes” to stroke mortality estimates for intracranial hemorrhagic stroke and ischemic stroke. There were marked differences in the fraction of death assigned to ischemic stroke and hemorrhagic stroke for unspecified stroke and hypertension between GBD regions and between age groups.

Conclusions

A large proportion of stroke fatalities is derived from the redistribution of “unspecified stroke” and “hypertension” with marked regional differences. Future advancements in stroke certification, data collections, and statistical analyses may improve the estimation of the global stroke burden.

Keywords: stroke, cerebrovascular diseases, epidemiology, ischemic stroke, hemorrhagic stroke

Introduction

The Global Burden of Diseases (GBD) 2013 results have confirmed that stroke remains a leading cause of mortality and disability adjusted life years (DALYs)[1]. These results further confirm findings from stroke reviews based on published stroke epidemiological studies that show marked variation in stroke rates between countries with especially high rates in low- and middle- income countries[2,3].

During the nearly 25 years of GBD estimation, there have been significant advancements in the epidemiologic modelling, and region/country specific reporting of causes of death (COD)[4]. The validity of diagnosis of stroke as a COD depends on access to health facilities, local coding practices, availability of CT/MRI imaging which is of particular importance when dividing the stroke estimates into ischemic stroke (IS) and hemorrhagic stroke (HS)[5,6]. A key issue in assessing the stroke mortality burden is that varying proportions of unspecified CODs are stroke events which are coded inaccurately, and the handling of these codes may impact estimated stroke mortality and the associated estimations of stroke incidence and prevalence rates. The proportion of routine mortality codes that are unspecific has remained constant at 29–33% since the launch the GBD, representing the so-called “garbage codes” (GCs), figure 1[7].

FIG. 1.

FIG. 1

Fraction of “garbage codes” in whole vital registration data with ICD9 and ICD 10 format at the global level, all ages, men and women combined, and by year

Every international classification of disease (ICD) code that is assigned to death but cannot be a specific underlying cause of death must be redistributed and during this process ambiguous codes are split to their likely specific cause. Ill-defined codes are codes that cannot be a cause of death, for example R54 (senility, ICD10). Because these types of GCs are completely ambiguous in the process of causes of death estimation, these events are assign on all specific causes of death. Intermediate codes are events coded secondary to a different underlying cause such as I50 (heart failure, ICD10).

We assigned these events to any cause that pathologically can be underlying cause for this intermediate cause. CODs that can be related to different specific disease categories, for example I10 (hypertension, ICD10) are assigned to any underlying causes of death that pathologically and directly will be due to this disorder.

The purpose of the current manuscript is to present the regional distribution of GCs and the impact on regional stroke mortality data for the GBD 2013.

Methodology

The methodology for the GBD 2013 estimates have been described previously[1]. In brief, all available mortality data were compiled and non-specific cause codes were redistributed based on literature review and statistical methods. The total for all cause-specific deaths was fit to an envelope for all-cause mortality for 240 specific causes, including ischemic stroke (IS) and hemorrhagic stroke (HS).

Specific GCs that have effects on cerebrovascular disease are shown in Figure 1. Especially “ill-defined codes”, “hypertension” and atherosclerosis”, and “unspecific stroke” are major contributing codes. International classification of diseases codes (ICD9 and ICD10) that were used for definition of IS, HS, and other GCs are shown in Table 1. Garbage codes were redistributed to their specific COD codes (target codes) by age, sex, country, and year. Target code reassignment was done one by one based on ICD classification and the pathology behind of each GC by checking of multiple causes of death and literature review.

Table 1.

Fraction of death coded due to each group of “garbage codes” that have been redistributed to each type of stroke, men and women combined, all ages, ICD 10 vital registration

different group of garbage codes Intracranial hemorrhagic stroke Ischemic stroke Subarachnoid hemorrhagic stroke
Stroke unspecified 30.8% 64.7% 4.5%
No traumatic extradural hemorrhage 74.3% 0.0% 25.7%
Hemiplegia 29.9% 54.6% 9.5%
Unspecified disorders of circulatory system in diseases 46.3% 18.5% 22.7%
Compression of brain 33.1% 0.0% 31.8%
Somnolence, stupor and coma 31.7% 27.3% 5.6%
Hypertensive encephalopathy 17.7% 27.4% 13.5%
Atherosclerosis 0.0% 50.5% 0.0%
Other and unspecified encephalopathy 0.0% 0.0% 38.3%
Pneumonitis due to solids and liquids 23.6% 14.7% 0.0%
Cerebral edema 0.0% 35.9% 0.0%
primary and secondary hypertension 6.7% 29.0% 0.0%
Cardiovascular disease, unspecified 12.2% 5.0% 4.5%
Convulsions 8.4% 3.0% 5.8%
Age-related physical debility(senility) 5.8% 8.6% 0.7%
Unspecified disorder of circulatory system 6.3% 3.4% 0.6%
Monoplegia 4.0% 4.7% 1.4%
Cardiac arrest, Hypotension, Syncope and collapse 4.7% 4.8% 0.5%
Aphagia and dysphagia 3.2% 5.9% 0.8%
Abnormalities of breathing, Cyanosis 4.0% 4.2% 1.3%
residual 3.4% 3.3% 0.8%
Asphyxia and hypoxemia, Respiratory arrest 3.1% 3.3% 0.9%
Amnestic disorder and Delirium due to known physiological condition 3.6% 2.8% 0.2%
Nausea and vomiting 2.7% 2.9% 0.0%
all ill-defined code 2.2% 1.7% 0.6%
Dehydration and Volume depletion 1.0% 1.5% 0.2%
Organ-limited amyloidosis 0.9% 0.9% 0.3%
Spastic hemiplegia, paraplegia, tetraplegia 0.9% 0.4% 0.6%
Secondary systemic amyloidosis 0.5% 0.5% 0.2%
Other disorders of brain and central nervous system 0.0% 0.5% 0.0%
Other disorders of brain 0.0% 0.5% 0.0%
Pulmonary edema 0.0% 0.0% 0.0%
Shock, unspecified 0.0% 0.0% 0.0%
Acute Respiratory failure, Acute respiratory distress syndrome 0.0% 0.0% 0.0%

We defined the pool of data as all mortality data coded to within the group’s undefined codes, or the group’s redistribution target codes for each country, year, age, and sex. We then ran the following regression as described in Ahern et al.[8]

TGcrt=α+βUcrt+γr+θrUcrt+εct

TGcrt: % of death data within a given undefined site code’s data pool, which were coded to specific site groups, by country (c), year (t) and with countries categorized into regions (r)-: % of death data within given undefined site code’s coded to undefined site code by country, year, region- fixed constant-: slope coefficient describing associated between and - : region-specific random intercept-: region specific random slope-: normally-distributed error 

If the coefficient was positive and statistically significant at a p<0.05 level the target group was dropped and the regression rerun. As an example, for the redistribution of the COD “hypertension” “chronic kidney disease due to hypertension” and “hypertensive heart disease” were initially included, but for these causes there were not any significant coefficient, and they were consequently omitted.

Furthermore, target codes were dropped if the coefficient was positive and statistically significant. The regression was then repeated a third time. After running the regression three times, the y-intercept was used as an estimate of an ideal, all-target, no undefined data pool. If there were multiple target groups, the y-intercepts for negative and statistically significant coefficients were scaled to sum 100% and the proportions for the different target codes were used to redistribute the undefined codes to the target code. We ran these regressions on added whole data set (ICD9 and ICD10) for one country (or region) by age and sex. Separate regressions were run for each sex and for the following three age groups within each sex: 0–14, 15–49, 50+.

Results

The redistribution of GCs to stroke and stroke subtypes varied markedly between regions, age, and sex.

For “unspecified stroke” almost all events in subjects aged less than 50 years assigned to intra-cranial stroke and subarachnoid hemorrhagic stroke; in the causes of death estimation these two types of hemorrhages are combined as hemorrhagic stroke (HS). In subjects aged 50 years or more mostly all “unspecified stroke” deaths are assigned to IS, Figure 3. Redistribution of “unspecified stroke” varied by region exemplified for men aged 50 to 69 years, Figure 4. In Eastern Europe almost all unspecified stroke events are assigned to IS whereas the majority of unspecified stroke events in South-East and Central Asia are assigned to ICH.

FIG. 3.

FIG. 3

Fraction of “unspecified stroke” assigned to the three type of stroke at the global level by age and sex.

Fig. 4.

Fig. 4

Fraction of “unspecified stroke” assigned to the three type of stroke by GBD region in men aged 50–69 years

For “hypertension” as a cause of death the redistribution to target codes by age and sex on the global level is shown in figure 5. In subjects aged less than 15 years, and in women aged 15 – 49 years, HS is the main target code. In men and in subjects aged 50 + years the majority of hypertensive deaths are assigned to ischemic heart disease and IS. The regional and global redistribution of deaths coded to hypertension to target codes exemplified by women aged 50 to 69 years is shown in Figure 6. In Southern Sub-Saharan Africa more than half of all hypertensive deaths were redistributed to intracranial hemorrhage. The highest proportion of hypertensive deaths assigned to IS occurred in Eastern Europe.

FIG. 5.

FIG. 5

Fraction of death coded due to hypertension assigned to the different target code by age and sex at the global level

FIG. 6.

FIG. 6

Fraction of death coded due to hypertension assigned to the different target codes in females aged 50 – 69 years, regional level

Other GCs that are redistributed to stroke (ICD 10) are listed in Table 1, and the fractions of deaths that have been added to each of the categories ICH, IS, and SAH are listed in Table 2. More than half of all ischemic stroke fatalities and nearly half of all ICH fatalities are derived from the redistribution of “unspecified stroke”.

Table 2.

Fraction of death that have been added to each type of stroke after redistribution of “garbage codes”, men and women combined, all ages, year 2008, ICD 10 vital registration

different group of garbage codes Intracranial hemorrhagic stroke Ischemic stroke Subarachnoid hemorrhagic stroke
Stroke unspecified 88.6% 162.8% 46.1%
primary and secondary hypertension 4.7% 17.7% 0.0%
Atherosclerosis 0.0% 21.6% 0.0%
Non traumatic extradural hemorrhage 6.0% 0.0% 7.4%
Age-related physical debility(senility) 4.9% 6.3% 2.0%
Pneumonitis due to solids and liquids 7.1% 3.8% 0.0%
all ill-defined code 2.7% 1.8% 2.7%
Cardiac arrest, Hypotension, Syncope and collapse 2.8% 2.5% 1.0%
Asphyxia and hypoxemia, Respiratory arrest 0.5% 0.5% 0.5%
residual 0.5% 0.4% 0.4%
Somnolence, stupor and coma 0.5% 0.4% 0.3%
Hypertensive encephalopathy 0.2% 0.3% 0.6%
Hemiplegia 0.3% 0.4% 0.3%
Cerebral edema 0.0% 0.5% 0.0%
Dehydration and Volume depletion 0.1% 0.1% 0.1%
Unspecified disorder of circulatory system 0.1% 0.1% 0.0%

Discussion

The GBD provides a unique opportunity for estimating stroke mortality and the associated burden on a global level, applying a standardized methodology taking into account all other major causes of death. A large proportion of stroke fatalities stems from the redistribution of especially “unspecified stroke”, and “hypertension”, as well as many other codes.

Ideally, the global burden of stroke should be based on “gold standard” stroke epidemiology data, however, there is a shortage of such data both from high-income countries and especially from low- and middle-income countries[3]. In the absence of ideal data routine mortality statistics are used relying on the certifying person’s ability to correctly assess and code what was the underlying cause of death. Previous studies from different countries have shown that the validity of stroke sub-type diagnoses varies[5,6,9]. Whereas “ischemic stroke” and “intra-cerebral hemorrhage” codes are often correct maybe by requiring a detailed level of knowledge of the cause of the subjects symptoms including access to scanning facilities, there is more uncertainty with regards to the validity of the diagnosis as this may be based on clinical signs alone without neuro-imaging. The access to health, healthcare, and imaging facilities varies between countries as well as between socio-economic groups between and within countries and could impact death certification and coding practice.

In regions without routine mortality statistics, knowledge about stroke as a cause of death may be derived from results based on verbal autopsy[10]. There are several examples of such studies from different countries where assessment of stroke has been examined[1113]. Differences in the development of disease algorithms could hamper the comparability, but represents a first-step in increasing the knowledge of cerebrovascular diseases as a cause of death.

For countries with no data available, for example some countries in North-Africa, the Middle-East, and large parts of Asia, the estimations are based on regional pattern and a full set of covariates that are available for all countries and for all years. Shortage on data causes uncertainty about the redistribution of GCs to target codes. As an example in this study, “hypertension” was very differently redistributed to ischemic heart disease, ischemic stroke, and intracranial hemorrhagic stroke in Eastern Europe as compared Central and Western Europe. Studies have suggested that there are marked differences in the occurrence of different subtypes of stroke between European populations[14,15]; the extent to which the current redistribution is consistent for all countries within each region is beyond the scope of this publication. However, it is an example of how increasing knowledge of stroke epidemiology and advancements in the statistical methods for redistributing CGs may lead to improvements in the future GBD methodology. Future results from large scale population based studies on stroke incidence, mortality and fatality[16] will be essential for refining regional GBD estimates.

In conclusion, stroke mortality data in the GBD is derived from routine statistics and the redistribution of ill-defined and other diagnostic codes which cannot be considered as specific causes of death. A large proportion of stroke fatalities is derived from the redistribution of “unspecified stroke” and “hypertension”. Regional differences are marked which is supported by real-world-data, however, future advancements in stroke certification, data collections, and statistical analyses may improve the estimation of the stroke mortality burden.

FIG. 2.

FIG. 2

Fraction of “garbage codes” in whole vital registration data with ICD 10 format at the global level, by age, men and women combined, for year 2005

Table 3.

ICD code for definition of ischemic stroke, hemorrhagic stroke, and garbage codes HS by ICD 9 and ICD 10, four digits code level

Cause
Name
ICD10 Code ICD9 Code
Ischemic stroke G45–G46.8,I63–I63.9,I65–I66.9,I67.2,I67.3,I67.5,I67.6,I69.3–I69.398 433–435.9,437.0,437.1,437.5–437.8
Hemorrhagic stroke I60–I61.9,I62.0–I62.03,I67.0,I67.1,I67.7,I69.0–I69.198,I69.20–I69.298 430–432.9,437.2
Garbage Code A01,A14.9,A29–A30.9,A40–A41.9,A45,
A45.9,A47–A48.0,A48.3,A48.8–A49.02,A49.2–A49.9,
A59–A62,A64,A64.0,A71–A73,A74.0,A76,A97,A99,A99.0,B07–B09,B11–B14,B17.8,
B17.9,B19,B19.0,B19.9,B28,B29,B30–B32.4,
B34–B36.9,B55,B55.1–B55.9,B61,B62,B64,B66–B66.9,
B73–B74.2,B76–B76.9,B79,
B82–B82.9,B83.9–B89,B92–B94.0,B94.8,B94.9,
B95.6–B99.9,C14–C14.9,C26–C29,C35,C36,C39–C39.9,C42,C46–C46.9,C55–C55.9,C57.9,C59,
C63.9,C68,C68.9,C75.9–C80.9,C87,C98–D00.0,D01,D01.4–D02,D02.4,D02.9,D07,D07.3–D07.39,
D07.6–D09,D09.1–D09.19,D09.9,D10,D10.9,D13,D13.9,D14,D14.4,D17–D21.9,
D26,D26.7,D26.9,D28,D28.9,D29,D29.9,D30,D30.9,
D36.0,D36.9–D37.0,D37.6–D38,D38.6–D39.0,D39.9,D40,
D40.9,D41,D41.9,D44,D44.9,D48,D48.7–D49.1,D49.5,D49.7,
D49.8,D49.89,D49.9,D54,D59,D59.4,D59.8,D59.9,D64,D65–D65.9,D75.9,D79,D84,D84.9,D85,D87,
D88,D89.8–D99,E07.8–E08.9,E17–E19,E34.9–E35.8,E37–E39,E47–E50.9,E62,E64.1,E69,E85.3–E87.70,
E87.79–E87.99,E90–E99.9,F04–F06.1,F06.3–F07.0,F07.2–F09.9,F12–F12.99,F17–F17.9,
F24,F30–F50,F50.2–G00,G00.9–G02.8,G03.9,G06–G09.0,G15–G19,G27–G29,
G32–G34,G38,G39,G42–G44.89,G47–G47.29,G47.4–G60.9,G62–G69,G74–G89.4,G91–G93.6,G93.8–G94.8,G96–G96.9,
G98–H69.93,H71–H99,I00.0,I03,I04,I10–I10.9,I14–I19,I26–I27.0,I27.2–I27.9,I28.9–I29.9,I31.2–I31.4,I32–I32.8,
I43–I46.9,I49–I51,I51.7–I59,I62,I62.1,I62.9,I64–I64.9,I67,I67.4,I67.8–I69,I69.2,I69.4–I70.1,
I70.9–I70.92,I79–I79.8,I90,I92–I95.1,
I95.8–I96.9,I98.4,I98.8,I99–J00.0,J02,J02.8–J03,J03.8–J04.31,J06–J08,J15.9,J17–J19.6,J22–J29,J48–J59,J64–J64.9,
J69–J69.9,J71–J81.9,J83,J85–J90.9,J93–J94.9,J96–K19,K23–K24,K30,K31.9–K34,K39,K47–K49,K53,K54,K58,K63–K63.4,K63.8–K63.9,K65–K66.1,K66.9,K69,K71–K71.2,K71.6,K71.8–K72.01,
K75–K75.1,K78,K79,K84,K87–K89,K92.0–K92.2,K92.9,K93,K93.1,K93.8,K96–K99,L06,L07,L09,L15–L50.9,L52–L87.9,L90–L92.9,L94–L96,L98.5–L99.8,M04,M10–M12.09,M12.2–M29,M37–M39,M43.2–M49,M49.2–M64,M65.1–M71,M71.2–M73,M73.8–M85.9,M87.2–M87.9,M89.1–M89.49,M90–M99.9,N09,
N13–N13.9,N17–N17.9,N19–N19.9,N24,N32.1,N32.2,N32.8–N33.8,N35–N35.9,N37–N38,N39.3–N40.9,N42–N43.42,N46–N48.9,N52–N64.9,N66–N69,N78,N79,N82–N82.9,N84,N84.2–N86,N88–N95.9,N97–N97.9,O08–O08.9,
O17–O19,O27,O37–O39,O49–O59,O78,O79,O93–O95.9,P06,P16–P18,P30–P34.2,P40–P49,P62–P69,P73,P79,P82,P85–P89,P96.9–P99.9,Q08–Q10.3,Q19,Q29,Q36.0–Q36.9,
Q46–Q49,Q88,Q89.9,Q94,Q96–Q96.9,Q98–Q98.9,
Q99.9–R19.6,R19.8–R50.1,R50.8,R50.81,R50.84–R72.9,
R74–R78,R78.6–R94.8,R95.0–T98.3,
U04.9,V87–V87.1,V87.4–V88.1,V88.4–V89.9,
V90.00,V99,V99.0,W47,W48,W63,W71,W72,W82,W95–W97,W98,X07,
X41–X42.9,X44–X44.9,X55,X56,X59–X59.9,Y09–Y34.9,Y85–Y87.0,Y87.2,Y89
000,000.9,002,030–030.9,038–038.9,039.6,040.0,041.9,054.1,067–070,070.4,
070.49,070.5,070.59,070.6,070.9,076–076.1,076.6,076.9–078.3,085,
085.1–085.9,089–089.9,108–111.9,
112.0,112.3–117.2,117.4–117.6,117.8–119,121–121.9,
125.0–125.3,126–126.9,127.3,130–134.9,
136.3–136.5,136.8,136.9,139.1,139.8,149–149.9,159–159.9,
165–169,176–179.9,183.9,184,184.5,184.9,187,187.9,189,189.9,194.9–199.9,209,209.2,209.20,209.29–209.30,209.6,
209.60,209.62,209.69–210,211,211.9,212,212.9,214–216.9,219,219.8,219.9,221,
221.9,222,222.9,223,223.9,229,229.1,229.9–230.0,230.9,231,231.8,231.9,
233,233.3,233.30,233.39,233.6,233.9,234,234.9,235,235.1–235.3,
235.5,235.9–236.0,236.3,236.6,236.9,236.90,238,238.9–239.1,239.5,
239.7–239.9,244,244.9,247–249.91,264–264.9,274–274.9,276.0–276.9,277.3,278,279.0–279.53,279.8,279.9,286.6,293–294.0,296–302.9,304,304.3–304.33,
304.9–304.93,305.2–305.23,306–307.0,307.2–307.53,307.59–320,
320.9,321.0,324–327.19,328,329,331.3,331.4,338–339.89,342–344.9,346–348.9,349.81–353.5,
354–355.9,357,357.8–357.9,360–380.9,384–389.9,399–401.9,405–409.4,415–416.0,
416.3–416.9,418–419.9,423.0,426–426.9,427.4–427.5,427.9–429,429.2–429.9,436–437,
437.3,437.4,437.9–440.9,458–458.9,459.0,459.5–460.9,462–465.9,482.9,483,484,484.8–486.9,505–505.9,507–507.9,510–514.9,515.0,
515.9,518–518.53,518.8–518.89,519,519.9–529.9,536.2,536.3,536.8,536.9,537.7,537.89,537.9,544–549,553.8,553.9,559,559.0,
560.4–560.7,561,562.2–563,564.8–564.9,567–569,569.49,569.79–569.83,569.86–570.9,572–572.2,573,573.5,578–578.9,584–584.9,
586–587.9,591–591.9,593.9,599.60–599.72,599.9–600.91,603–603.9,605–609,611–612.1,615–616.9,618–619.9,621–621.35,622–622.2,622.8–628.9,629.89,629.9,637–637.92,639–639.9,690–693.9,695.8–706.9,
708–709.9,712–713.8,714.4,715–716,716.1–728.85,728.87,728.89–729.99,730.3–730.39,730.7–730.79,731–731.9,733–739.9,749.1–749.14,758.7,759,759.9,770.0,779.9–780.56,780.58–780.61,780.64–786.02,
786.04–787.04,787.2–787.9,787.99,788,788.1–790.1,790.29,790.4–798,798.1–999.9,E80,E80.08,E80.09,E80.18,E80.19,E80.28,E80.29,E80.38,E80.39,
E80.48,E80.49,E80.58,E80.59,E80.68,E80.69,E80.78–E81.0,E81.08–E81.1,E81.18–E81.2,E81.28–E81.3,E81.38–E81.4,E81.48–E81.5,E81.58–E81.6,E81.68–E81.7,E81.78–E81.8,E81.88–E81.9,E81.98–E82.0
,E82.08–E82.1,E82.18–E82.2,E82.28–E82.3,E82.38–E82.4,E82.48–E82.5,E82.58–E82.6,E82.68–E82.7,E82.78–E82.8,E82.88–E82.9,E82.98–E83,E83.9,E85,E85.58–E85.599,
E85.9,E87,E87.7,E88.7–E88.709,E91.4–E91.409,
E92.89–E92.90,E92.95–E92.99,E98.0–E98.9,V01–V29.9

Footnotes

Disclaimer: The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the U.S. Department of Health and Human Services.

Contributor Information

Thomas Truelsen, Department of Neurology, University of Copenhagen Rigshospitalet, Copenhagen, Denmark.

Lars-Henrik Krarup, Department of Neurology, University of Copenhagen Rigshospitalet, Copenhagen, Denmark.

Helle Iversen, Department of Neurology, University of Copenhagen Rigshospitalet, Copenhagen, Denmark.

George A. Mensah, Center for Translation Research and Implementation Science (CTRIS), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA

Valery Feigin, National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.

Luciano Sposato, Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University. London, Ontario. Canada.

Mohsen Naghavi, Professor of Global Health Department, Institute for Health Metrics and Evaluation University of Washington.

Reference list

  • 1.GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–171. doi: 10.1016/S0140-6736(14)61682-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C Global Burden of Diseases I, Risk Factors S, the GBDSEG. Global and regional burden of stroke during 1990–2010: Findings from the global burden of disease study 2010. Lancet. 2014;383:245–254. doi: 10.1016/s0140-6736(13)61953-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 2009;8:355–369. doi: 10.1016/S1474-4422(09)70025-0. [DOI] [PubMed] [Google Scholar]
  • 4.Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Population Health Metrics. 2010;8:9. doi: 10.1186/1478-7954-8-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a national register of patients. Neuroepidemiology. 2007;28:150–154. doi: 10.1159/000102143. [DOI] [PubMed] [Google Scholar]
  • 6.Jones SA, Gottesman RF, Shahar E, Wruck L, Rosamond WD. Validity of hospital discharge diagnosis codes for stroke: The atherosclerosis risk in communities study. Stroke. 2014;45:3219–3225. doi: 10.1161/STROKEAHA.114.006316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.CJL Murray and Lopez (eds.), global burden of disease and injury series. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, harvard school of public health, on behalf of the world health organization and the world bank, boston (1996), pp 117–200:1996, pp 117–200.
  • 8.Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: The rise of ischemic heart disease. Popul Health Metr. 2011;9:8. doi: 10.1186/1478-7954-9-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Malmivaara A, Meretoja A, Peltola M, Numerato D, Heijink R, Engelfriet P, Wild SH, Häkkinen U Belicza utility of global cardiovascular mortality data: The rise of ischemi T. Comparing ischaemic stroke in six European countries. The Eurohope Register Study European journal of neurology: the official journal of the European Federation of Neurological Societies. 2015;22:284–291. e225–286. doi: 10.1111/ene.12560. [DOI] [PubMed] [Google Scholar]
  • 10.Joshi R, Kengne AP, Neal B. Methodological trends in studies based on verbal autopsies before and after published guidelines. Bull World Health Organ. 2009;87:678–682. doi: 10.2471/BLT.07.049288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kalkonde YV, Deshmukh MD, Sahane V, Puthran J, Kakarmath S, Agavane V, Bang A. Stroke is the leading cause of death in rural gadchiroli, india: A prospective community-based study. Stroke. 2015;46:1764–1768. doi: 10.1161/STROKEAHA.115.008918. [DOI] [PubMed] [Google Scholar]
  • 12.Walker R, Whiting D, Unwin N, Mugusi F, Swai M, Aris E, Jusabani A, Kabadi G, Gray WK, Lewanga M, Alberti G. Stroke incidence in rural and urban tanzania: A prospective, community-based study. Lancet Neurol. 2010;9:786–792. doi: 10.1016/S1474-4422(10)70144-7. [DOI] [PubMed] [Google Scholar]
  • 13.Sepanlou SG, Sharafkhah M, Poustchi H, Malekzadeh MM, Etemadi A, Khademi H, Islami F, Pourshams A, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Esteghamati A, Kamangar F, Malekzadeh R. Hypertension and mortality in the golestan cohort study: A prospective study of 50 000 adults in Iran. J Hum Hypertens. 2015 doi: 10.1038/jhh.2015.57. [DOI] [PubMed] [Google Scholar]
  • 14.Ingall T, Asplund K, MMM, Poustchi H, Malekzadeh MM, Etemadi A, Khademi H, Islami F, Pourshams A, Pharoah PD, Abnet CC. MONICA stroke study. Stroke. 2000;31:1054–1061. doi: 10.1161/01.str.31.5.1054. [DOI] [PubMed] [Google Scholar]
  • 15.Truelsen T. MM Mke. 2000;31:1054–1061. [Google Scholar]; Malekzadeh MM, Etemadi A, Khademi H, Islami F, Pourshams A, Pharoah PD, Abnet CC, Brennan P. Boffeca project. Stroke. 2003;34:1346–1352. [Google Scholar]
  • 16.Sposato LA, Coppola ML, Altamirano J, Borrego Guerrero B, Casanova J, De Martino M, Díaz A, Feigin VL, Funaro F, Gradillone ME, Lewin ML, Lopes RD, López DH, Louge M, Maccarone P, Martens C, Miguel M, Rabinstein A, Morasso H, Riccio PM, Saposnik G, Silva D, Suasnabar R, Truelsen T, Uzcudun A, Viviani CA, Bahit MC. Program for the epidemiological evaluation of stroke in tandil, argentina (PREVISTA) study: Rationale and design. Int J Stroke. 2013;8:591–597. doi: 10.1111/ijs.12171. [DOI] [PubMed] [Google Scholar]

RESOURCES